Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ardelyx Inc (ARDX)

Ardelyx Inc (ARDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ardelyx Inc 400 Fifth Avenue Suite 210 Waltham MA 02451 USA

P: 510-745-1700

Description:

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.

Key Statistics

Overview:

Market Capitalization, $K 88,393
Shares Outstanding, K 144,599
Annual Sales, $ 10,100 K
Annual Net Income, $ -158,170 K
Last Quarter Sales, $ 470 K
Last Quarter Net Income, $ -28,070 K
60-Month Beta 1.81
% of Insider Shareholders 5.95%
% of Institutional Shareholders 32.35%
Float, K 135,995
% Float 94.05%
Short Volume Ratio 0.40

Growth:

1-Year Return -69.01%
3-Year Return -3.73%
5-Year Return -57.47%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 45.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 05/05/22
Next Earnings Date 08/12/22
Earnings Per Share ttm -1.39
EPS Growth vs. Prev Qtr 32.26%
EPS Growth vs. Prev Year 38.24%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 07/20/21

ARDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -177.07%
Return-on-Assets % -93.46%
Profit Margin % -1,566.04
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 8.51
Price/Cash Flow N/A
Price/Book 1.33
Book Value/Share 0.45
Interest Coverage -34.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar